Abstract Traumatic brain injury (TBI) disrupts tissue homeostasis resulting in pathological apoptotic activation. Recently, caspase-12 was reported to be induced and activated by the unfolded protein response following excess endoplasmic reticulum (ER) stress. This study examined rat caspase-12 expression using the controlled cortical impact TBI model. Immunoblots of fractionalized cell lysates found elevated caspase-12 proform (60 kDa) and processed form (12 kDa), with peak induction observed within 24 h post-injury in the cortex (418% and 503%, respectively). Hippocampus caspase-12 proform induction peaked at 24 h post-injury (641%), while processed form induction peaked at 6 h (620%). Semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis confirmed elevated caspase-12 mRNA levels after TBI. Injury severity (1.0, 1.2 or 1.6 mm compression) was associated with increased caspase-12 mRNA expression, peaking at 5 days in the cortex (657%, 651% and 1259%, respectively) and 6 h in the hippocampus (435%, 451% and 460%, respectively). Immunohistochemical analysis revealed caspase-12 induction in neurons in both the cortex and hippocampus as well as in astrocytes at the contusion site. This is the first report of increased expression of caspase-12 following TBI. Our results suggest that the caspase-12-mediated ER apoptotic pathway may play a role in rat TBI pathology independent of the receptor-or mitochondria-mediated apoptotic pathways.
Traumatic brain injury (TBI) causes progressive neuronal degeneration resulting from acute and delayed cell death that is mediated in part by caspases (Yakovlev et al. 1997; Clark et al. 1999 Clark et al. , 2000 . Previously, necrosis was thought to be the primary mode of cell death after TBI, but current reports have implicated apoptosis in the neuropathology of TBI (Rink et al. 1995; Colicos et al. 1996; Yakovlev et al. 1997; Conti et al. 1998; Newcomb et al. 1999; Clark et al. 2000) . Apoptosis is critical to the sculpting and pruning of the CNS during development (Oppenheim 1991; Raff et al. 1993; Vaux and Korsmeyer 1999) and for homeostasis of tissues that require the elimination of aged and abnormal cells (Johnson et al. 1999) . However, while apoptosis is normally under strict control, during acute and chronic pathological conditions such as after stroke or TBI, apoptosis can contribute to neuronal death. To date, studies of apoptosis in TBI have concentrated on two caspase-mediated apoptotic pathways termed the extrinsic and intrinsic pathways (Daniel 2000; Yakovlev and Faden 2001) . The extrinsic pathway is initiated by the binding of specialized ligands to a family of plasma membrane receptors termed death receptors that results in the activation of caspases-8/10. In contrast, the intrinsic pathway involves the release of cytochrome c from the mitochondria which, in turn, activates caspase-9. Both pathways ultimately lead to the activation of caspase-3. Recently, a novel caspase-12-mediated apoptotic pathway has been described that involves endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) .
The protease family of caspases plays a key role in the implementation of apoptosis in vertebrates (Jacobson et al. 1997) . They are constitutively expressed as precursor proteins (pro-caspases) and are believed to have little or no enzymatic activity. Once activated, they are processed into large subdomains of approximately 20 kDa (p20) and small subdomains of approximately 10 kDa (p10) (Cohen 1997) that form heterotetramers, which possess enzymatic activity. The caspase family has been divided into two broad functional categories: initiator caspases (caspase-8, -9, -10 and -12) and effector caspases (caspase-3, -6 and -7). The initiator caspases are upstream in the apoptotic pathway and respond to apoptotic stimuli by undergoing autoproteolytic activation. The downstream effector caspases are processed by the active initiator caspases and are responsible for dismantling cellular structure. Recent studies have shown that caspase-12 functions as an initiator caspase and has been implicated in ER stress-induced apoptosis Rao et al. 2001 Rao et al. , 2002 Yoneda et al. 2001) .
The ER plays a critical role in a variety of processes, including protein synthesis and folding, and the maintenance of Ca 2+ homeostasis. A number of recent studies demonstrate that ER stress causes the disruption of these and other normal functions and thus, the ER has garnered increased interest for its putative role in cellular pathology. In addition, the disruption of ER homeostasis is considered a causal factor in pathologically-relevant apoptosis and has been implicated in several neurodegenerative disorders (Aridor and Balch 1999; Soto 2003) . For example, disruption of Ca 2+ homeostasis leads to increased levels of cytosolic Ca 2+ , which induce pathological activation of calpains after TBI (Pike et al. 1998) , and the translocation of calpains to the ER surface where they can activate caspase-12 . Recent attention has centered on the role of caspase-12 and its unique functional characteristic of being specifically activated by ER stress. For example, have shown that caspase-12-deficient cells are resistant to inducers of ER stress-induced apoptosis. The molecular mechanisms by which caspase-12 mediates apoptosis are still under investigation, but recent work suggests that it functions by cleaving pro-caspase-9 without the involvement of cytochrome c and the apoptosome (Rao et al. 2001 (Rao et al. , 2002 Morishima et al. 2002) . The hypothesized pathway of caspase activation in response to ER stress is active caspase-12 activates caspase-9 which, in turn, activates caspase-3 (Rao et al. 2001 (Rao et al. , 2002 Morishima et al. 2002) . Importantly, this hypothesis suggests a putative therapeutic target that is temporally upstream of those focused on attenuating the mitochondrial-mediated (intrinsic) or extrinsic pathway.
This study tests the hypothesis that TBI induces increased expression of caspase-12 mRNA and protein levels that are related to injury severity in the cortex and hippocampus of rats, and that this expression is found primarily in neurons. Using a rodent model of lateral controlled cortical impact injury, this investigation characterized the time course for induction of caspase-12 mRNA, up-regulation of the zymogen and cleavage of caspase-12 into its processed and alleged active form. Induction of caspase-12 mRNA was observed with semi-quantitative real-time polymerase chain reaction (PCR) analysis within 6 h of TBI in the hippocampus and within 3 days in the cortex. Immunoblot analyses of the caspase-12 proform (60 kDa) and processed form (12 kDa) showed increased protein expression within 6 h as well. Immunochemical analyses revealed that caspase-12 was induced in neurons in both the ipsilateral cortex and hippocampus. There was also evidence that caspase-12 was up-regulated in astrocytes at the contusion site. Our findings demonstrate that caspase-12 is rapidly induced and processed after TBI, suggesting that caspase-12 may be an important upstream mediator and part of a newly discovered pathway leading to apoptosis following TBI.
Materials and methods
Surgical preparation and controlled cortical impact traumatic brain injury A previously described cortical impact injury device was used to produce TBI in adult rats (Dixon et al. 1991; Pike et al. 1998) . Cortical impact TBI results in cortical deformation within the vicinity of the impactor tip associated with contusion, and neuronal and axonal damage that is confined to the hemisphere ipsilateral to the site of injury. Adult male (280-300 g) Sprague-Dawley rats (Harlan, Indianapolis, IN, USA) were anesthetized with 4% isoflurane in a carrier gas of 1 : 1 O 2 /N 2 O (4 min), followed by maintenance anesthesia of 2.5% isoflurane in the same carrier gas. Core body temperature was monitored continuously by a rectal thermistor probe and maintained at 37 ± 1°C by placing an adjustable temperature controlled heating pad beneath the rats. Animals were mounted in a stereotactic frame in a prone position and secured by ear and incisor bars. A mid-line cranial incision was made, the soft tissues were reflected, and a unilateral (ipsilateral to site of impact) craniotomy (7 mm diameter) was performed adjacent to the central suture, midway between bregma and lambda. The dura mater was kept intact over the cortex. Brain trauma was produced by impacting the right cortex (ipsilateral cortex) with a 5 mm diameter aluminum impactor tip (housed in a pneumatic cylinder) at a velocity of 3.5 m/s with a 1.0 mm, 1.2 mm or 1.6 mm compression and 150 ms dwell time (compression duration). Velocity was controlled by adjusting the pressure (compressed N 2 ) supplied to the pneumatic cylinder. Velocity and dwell time were measured by a linear velocity displacement transducer (Lucas Shaevitz model 500 HR, Detroit, MI, USA) that produces an analog signal recorded by a storage-trace oscilloscope (BK Precision, model 2522B, Placentia, CA, USA). Sham-injured animals underwent identical surgical procedures but did not receive an impact injury. Naïve animals received no surgery or injury. Appropriate pre-and post-injury management was maintained, and these measures complied with all guidelines set forth by the University of Florida Institutional Animal Care and Use Committee and the National Institutes of Health guidelines detailed in the Guide for the Care and Use of Laboratory Animals.
Tissue lysis and protein purification Cortical and hippocampal tissues were collected from naïve animals or at 6 h to 14 days after sham injury or TBI. At the appropriate post-injury time-points, the animals were anesthetized with 4% isoflurane in a carrier gas of 1 : 1 O 2 /N 2 O (4 min) and subsequently killed by decapitation. Ipsilateral and contralateral (to the impact site) cortices and hippocampi were rapidly dissected and snapfrozen in liquid nitrogen. Tissue samples were stored at ) 20°C. The samples were homogenized in a glass tube with a Teflon dounce pestle in 15 volumes of ice-cold detergent-free buffer [50 mM TrisHCl, pH 7.4, 1 mM EDTA, 2 mM EGTA, 0.33 M sucrose, 1 mM dithiothreitol (DTT)] containing a broad-range protease inhibitor cocktail (Roche Molecular Biochemicals, Indianapolis, IN, USA). Samples were centrifuged at 8000 g for 5 min at 4°C to remove the nuclei and mitochondria in order to increase the ER and cytosolic protein concentration. The subcellular supernatant fluids containing the lysosomal/ER and cytosolic proteins were then collected and sonicated for immunoblot analysis.
Immunoblot analysis
Protein concentrations of the subcellular tissue homogenate fractions were determined by the Detergent Compatible (DC) Assay for Protein (Bio-Rad Laboratories, Hercules, CA, USA) with albumin standards. Aliquots (40 lg) of each sample were prepared for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) by addition of 8· loading buffer [1· loading buffer contains 125 mM Tris-HCl (pH 6.8), 100 mM 2-mercapto-ethanol, 4% SDS, 0.01% bromophenol blue and 10% glycerol]. Samples with loading buffer were heated for 10 min at 96°C, centrifuged for 1 min at 10 000 g, and then resolved by SDS-PAGE on 4-20% Tris/glycine gels (Invitrogen Life Technologies, Carlsbad, CA, USA) at 150 V for 90 min at room temperature. Following electrophoresis, fractionated proteins were transferred to Immobilon-P polyvinylidene fluoride (PVDF) membrane (Millipore, Bedford, MA, USA) by the semi-dry method in a transfer buffer containing 39 mM glycine, 48 mM Tris and 5% methanol at 20 V for 2 h at room temperature. Ponceau Red (Sigma, St. Louis, MO, USA) was used to stain membranes to confirm successful transfer of protein and to insure that an equal amount of protein was loaded in each lane. Blots were blocked for 1 h at room temperature in 5% non-fat milk in TBST (20 mM Tris-HCl, 150 mM NaCl and 0.003% Tween-20, pH 7.5).
Immunoblots were probed with either the anti-b-actin monoclonal antibody to confirm equal amounts of protein loading (SigmaAldrich Co., St Louis, MO, USA) or anti-caspase-12 generated by Drs Michael Kalai and Peter Vandenabeele at the Flanders Interuniversity Institute for Biotechnology, University of Ghent, Ghent, Belgium. Following overnight incubation at 4°C (at 1 : 3000 for both primary antibodies) in 3% blocking solution plus 1% bovine serum albumin, blots were incubated for 1 h at room temperature in 3% non-fat milk/TBST containing a biotinylatedconjugated goat-anti-rabbit IgG (1 : 5000, Amersham Life Science, Inc., Arlington Heights, IL, USA). Blots were then incubated for 30 min at room temperature in TBST containing a streptavidin alkaline phosphatase conjugate (1 : 5000, Amersham Life Science, Inc.). Bound antibodies were visualized at room temperature by color development with BCIP/NBT Phosphatase Substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD, USA).
Immunochemistry analysis
Brain tissues were collected from animals with naïve or with 1 day TBI. At the appropriate time-point, the animals were anesthetized using 4% isoflurane in a carrier gas of 1 : 1 O 2 /N 2 O (4 min) and subsequently killed by decapitation after transcardial perfusion. The animals were perfused with 200 mL 2% heparin (Elkins-Sinn, Inc., Cherry Hill, NJ, USA) in 0.9% saline (pH 7.4) followed by 400 mL 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). A total of 2 h in fix was followed by storage in either phosphate-buffered saline (PBS) or cryoprotection buffer.
Vibratome-cut 40 lm sections were fluorescent immunolabeled with cell type-specific monoclonal antibodies, the anti-caspase-12 polyclonal antibody and a nuclear counterstain. Briefly, tissue sections were rinsed in PBS then incubated for 1 h at room temperature in 2% goat serum/2% horse serum/0.2% Triton-X 100 in Tris-buffered saline (TBS; block) to decrease non-specific labeling. The sections were then incubated with two primary antibodies: the anti-caspase-12 (IN) antibody (Cell Signaling, Technologies, Beverly, MA, USA) at a concentration of 1 : 500, and either the mouse anti-neuron-specific nuclear protein antibody (neuronal nuclei-anti-NeuN) at a concentration of 1 : 1000 (Chemicon, Temecula, CA, USA), or the mouse astrocyte-specific antiglial fibrillary acidic protein antibody (anti-GFAP) at a concentration of 1 : 1000 (Roche Molecular Biochemicals, Mannheim, Germany), for 4 days in block at 4°C. After being rinsed in TBST, the tissue sections were incubated with species-specific Alexa Fluor (Molecular Probes, Inc., Eugene, OR, USA) secondary antibodies at a concentration of 1 : 3000 in block for 1 h at room temperature. The sections were then washed in PBS, cover-slipped in Vectashield with DAPI (Vector Laboratories), viewed and digitally-captured with a Zeiss Axioplan 2 microscope equipped with a Spot Real Time (RT) Slider high resolution color CCD digital camera (Diagnostic Instruments, Inc., Sterling Heights, MI, USA). Sections without primary antibodies were similarly processed to control for binding of the secondary antibodies. On control sections, no specific immunoreactivity was detected.
RNA purification
Total RNA was isolated from control and injured samples of cortical or hippocampal tissue using TRIzol reagent (Gibco BRL, Rockville, MD, USA). Isopropanol precipitation and ethanol washes were performed according to the manufacturer's instructions. Samples were resuspended in 50-100 lL DEPC-treated water.
Reverse transcription
Total RNA (3 lg) was incubated with 1 lL oligo(dT) (0.5 mg/mL, Gibco BRL) at 70°C for 10 min, then at 4°C for 5 min. A reverse transcription reaction mixture was added to the RNA-oligo(dT) sample for a final volume of 20 lL, containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 5 mM MgCl 2 , 500 lM dNTPs, 10 mM DTT, 50 U SuperScript II reverse transcriptase (Gibco BRL) and 40 U RNaseOUT recombinant ribonuclease inhibitor (Gibco BRL). The sample was incubated at 42°C for 55 min, 70°C for 15 min for enzyme denaturation, and then transferred to 4°C. Each sample was diluted to a final volume of 100 lL with DEPC-treated water.
Primer selection
Caspase-12-specific primers For all base pair designations, refer to GeneBank locus AF317633, Rattus norvegicus caspase-12. 5¢C12 (gcacattcctggtctttatgtccc, bp 743-766) recognizes an upstream mRNA-specific sequence in caspase-12 transcripts. 3¢C12 (gccactgctgatacagatgaggaa, bp 961-984) recognizes a downstream caspase-12 mRNA-specific sequence.
GAPDH-specific primers
For all base pair designations for GAPDH-specific primers, refer to GeneBank locus AF106860. The upstream primer is designated 5¢GPD (ggctgccttctcttgtgac, bp 903-921) and the downstream primer is designated 3¢GPD (ggccgcctgcttcaccac, bp 1624-1641).
Standard PCR
A PCR reaction buffer was added to 2 lL of reverse transcription product for a final volume of 25 lL containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 2.5 mM MgCl 2 , 200 lM dNTPs, 0.5 lM dNTPs, 6% DMSO and 1.25 U Taq DNA polymerase (Gibco BRL). The mixture was then transferred to a PCR apparatus for amplification. Each denaturation, annealing and extension step was held for 30 s (two cycles of 95°C, 65°C and 72°C; then two cycles of 95°C, 62.5°C and 72°C; then 32 cycles of 95°C, 60°C and 72°C). Aliquots of PCR products were loaded onto 1.5% agarose gels and separated by electrophoresis in TAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH 7.5) containing 5 lg/mL ethidium bromide. To assay for genomic DNA contamination, RNA samples underwent PCR amplification without prior reverse transcription. Any samples showing genomic contamination underwent repurification and repeat assay for genomic contamination prior to PCR analysis for transcript expression.
Semi-quantitative/LightCycler PCR Real-time PCR was performed using a LightCycler rapid thermal cycler system (Roche Diagnostics) according to the manufacturer's instructions. Reactions were performed in a 10 lL volume with 0.5 lM primers and 2.5 mM MgCl 2 . Other reagents including nucleotides, FastStart Taq DNA polymerase and buffer were used as provided in the LightCycler-FastStart DNA Master SYBR Green I reaction mix (Roche Diagnostics). The amplification protocol included: 5 min 95°C denaturation; one cycle with 95°C denaturation for 5 s, 65°C annealing for 10 s and 72°C extension for 35 s; one cycle with 95°C denaturation for 5 s, 62.5°C annealing for 10 s and 72°C extension for 35 s; then 30-40 cycles of 95°C denaturation for 5 s, 60°C annealing for 10 s and 72°C extension for 35 s. Detection of the fluorescent product occurred at the end of the 72°C extension periods. Specificity of the amplification product from each primer pair was confirmed by melting curve analysis of the PCR product and subsequent gel electrophoresis.
Quantification was performed by online monitoring for identification of the exact time-point at which the logarithmic linear phase could be distinguished from the background (crossing point). The crossing point is expressed as a cycle number.
Standard curve preparation and semi-quantitative PCR analysis
Maximal caspase-12 mRNA expression was identified between 6 h (cortex) and 1 day (hippocampus) after injury. The reverse transcription (RT) product from ipsilateral cortical and hippocampal RNA collected 6 h (cortex) and 1 day (hippocampus) after injury underwent serial dilution, creating a standard curve of 100%, 33%, 11% and 3.7% of original RT product. Each dilution from the standard curve was analyzed with the LightCycler PCR using primer sets for caspase-12 or GAPDH mRNA. For each primer set, a crossing point cycle number was determined for each dilution of the standard curve. Linear regression analysis of the logarithm of the dilution factor versus the crossing point cycle number generated a standard curve for each transcript-specific primer set. From each primer set's standard curve, a crossing point cycle number could be converted to a relative amount of RNA. For individual samples, the crossing point cycle number was identified with the LightCycler PCR. Using the standard curve for each primer set, the amount of caspase-12 or GAPDH mRNA was determined. The amount of each transcript in sham-injured animals was set at 100%, and the level of expression in an impact-injured sample was calculated as a percentage of sham-injured expression.
Statistical analyses
For the immunoblots (n ¼ 4), semi-quantitative analysis was performed by computer-assisted densitometric scanning (ImageJ, version 1.29x, NIH, USA). Data were acquired as integrated densitometric values and transformed to percentages of the densitometric levels obtained from naïve animals visualized on the same blot. One-way ANOVA with Dunnett's multiple comparison tests was performed on the data using GraphPad Prism Version 3.03 for Windows (GraphPad Software, San Diego, CA, USA, http:// www.graphpad.com). The 1 day and 7 day densitometric values for sham-injured animals were pooled after analysis by one-way ANOVA with Dunnett's multiple comparison tests for each specific day revealed no statistical differences. All values are given as mean ± SEM. Differences were considered significant if p < 0.05.
Verification that the semi-quantitative PCR method yielded results similar to northern blot analysis was shown in a previous paper by our laboratory (Tolentino et al. 2002) . In summary, the northern blot analysis demonstrated a temporal profile of transcript induction in response to cortical injury. A linear regression analysis was performed comparing mRNA expression determined by PCR and northern blot, and the results from northern blot and PCR analyses fit a linear correlation with a slope ¼ 1.01, r 2 ¼ 0.95. A semi-quantitative PCR strategy that independently measures mRNA transcript levels has two major advantages over northern blot analyzes: (i) PCR amplification allows for detection of much lower levels of transcript expression, which is important for the analysis of caspase-12 mRNA expression in the brain; and (ii) a PCR-based approach decreases the amount of total RNA required for analysis, thereby facilitating analysis of smaller tissue samples and obviating the need to pool RNA samples prior to analysis. One-way ANOVA with Dunnett's multiple comparison tests was performed on the semi-quantitative PCR data using GraphPad Prism Version 3.03 for Windows. The data were normalized using logarithmic transformation. All values are given as mean ± SEM. Differences were considered significant if p < 0.05.
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Results
Immunoblot analysis of caspase-12 expression after traumatic injury Total cellular fractions, less nuclear and mitochondrial components as described above for the 1.6 mm cortical impact injury, were prepared from rat ipsilateral cortex and hippocampus to test the results of one of the three injury levels examined in the mRNA expression experiments. Caspase-12 expression was examined using the anti-caspase-12-specific antibody (Belgium), quantified by densitometric analysis and expressed as percentage of naïve control levels adjusted for the sham effect (Figs 1 and 2 ). Figures 1(a) and 2(a) show immunoblot analyses for caspase-12 expression in rat ipsilateral cortex and hippocampus, respectively, for naïve and sham-injured control animals, and for TBI animals from 6 h to 14 days post-injury. Using the anticaspase-12 antibody (Belgium), two distinct protein bands were identified: an approximately 60 kDa band corresponding to the zymogen (pro-casp12) and an approximately 12 kDa band that represents the small subunit of the active form of caspase-12 (Rao et al. 2001) . Immunoblots were also run with equivalent amounts of protein and probed with the anti-b-actin antibody, which served as an internal control for (a) (b) Fig. 1 Immunoblot analysis of pro-and active caspase-12 expression in ipsilateral cortical protein samples (n ¼ 4 animals) using the anticaspase-12-specific antibody (Belgium). (a) Samples were collected from naïve (N) rats, sham-operated rats 1 and 7 days after surgery (S1, S7), and from injured rats (1.6 mm impact) 6 h to 14 days after injury (6 h, 1d, 3d, 5d, 7d and 14d). The full-length caspase-12 protein and cleaved product (sizes in kDa) are indicated. Naïve rats served as injury controls. b-actin was directly assessed as an internal methods control. Since b-actin may itself be cleaved by caspases, blots were examined for cleaved fragments, but no fragments were detected. (b) Quantitative analysis: immunoblot analyses using the anti-caspase-12 antibody (Belgium) were quantified by densitometry and the levels of caspase-12 (pro-and active) expression in the ipsilateral cortex of injured animals after adjustment for the sham effect were calculated as a percentage of naïve control caspase-12 expression. One-way ANOVA with Dunnett's multiple comparison tests was performed to evaluate statistical significance. Comparison of caspase-12 expression in injured animals with naïve control animals adjusted for sham effect showed increased levels of expression that were statistically significant at 6 h, 1 day and 3 days post-injury for pro-caspase-12 ( ## p < 0.01) and cleaved caspase-12 (**p < 0.01).
(a) (b) Fig. 2 Immunoblot analysis of pro-and active caspase-12 expression in ipsilateral hippocampal protein samples (n ¼ 4 animals) using the anti-caspase-12-specific antibody (Belgium). (a) Samples were collected from naïve (N) rats, sham-operated rats 1 and 7 days after surgery (S1, S7), and from injured rats (1.6 mm impact) 6 h to 14 days after injury (6 h, 1d, 3d, 5d, 7d and 14d). The full-length caspase-12 protein and cleaved product (sizes in kDa) are indicated. Naïve rats served as injury controls. b-actin was directly assessed as an internal methods control. Since b-actin may itself be cleaved by caspases, blots were examined for cleaved fragments, but no fragments were detected. (b) Quantitative analysis: immunoblot analyses using the anti-caspase-12 antibody (Belgium) were quantified by densitometry and the levels of caspase-12 (pro-and active) expression in the ipsilateral hippocampus of injured animals were calculated after adjustment for the sham effect as a percentage of naïve control caspase-12 expression. One-way ANOVA with Dunnett's multiple comparison tests was performed to evaluate statistical significance. Comparison of caspase-12 expression in injured animals with naïve control animals adjusted for sham effect showed increased levels of expression that were statistically significant at 6 h and 1, 3 and 5 days post-injury for pro-caspase-12 ( # p < 0.05, ## p < 0.01) and 6 h and 1 day following injury for cleaved caspase-12 (**p < 0.01).
protein loading and transfer. Loading and transfer were essentially equivalent in all wells, as shown by comparable 42 kDa signal intensities.
Immunoblot analysis of caspase-12 expression in cortex after traumatic injury Tissue from sham-operated animals showed a modest increase in caspase-12 proform expression 1 day after craniotomy that was not statistically significant and declined to naïve levels by 7 days (Fig. 1a) . After adjustment for sham effect, significant induction of the caspase-12 proform was observed within 6 h of cortical injury (p < 0.01) and peaked on day 1 (418% ± 30%, p < 0.01). Elevated expression was also detected 3 days post-injury before declining to naïve levels by 7 days (Fig. 1b, p < 0.01) . Increased levels of processed caspase-12 were also observed within 6 h after cortical injury, with peak expression 1 day after injury (503% ± 40%, p < 0.01). Elevated expression levels continued to be statistically significant up to 3 days following injury before declining to near naïve levels (Fig. 1b) .
Immunoblot analysis of caspase-12 expression in hippocampus after traumatic injury
Hippocampi from sham-injured animals showed a slight increase in proform and processed caspase-12 expression 1 day after craniotomy that was not statistically significant and declined to naïve levels by 7 days (Fig. 2a) . After adjustment for the sham effect, elevated levels of caspase-12 induction for both the proform (p < 0.01) and processed form (p < 0.01) were observed within 6 h of TBI. In fact, levels of processed caspase-12 expression peaked at this early time-point (620% ± 46%) and remained significantly elevated 1 day post-injury ( Fig. 2b) . Pro-caspase-12 induction peaked later at 1 day after injury (641% ± 124%) and expression remained significantly elevated at 3 and 5 days following injury (Fig. 2b) . Compared to the ipsilateral cortex, the ipsilateral hippocampus possessed greater caspase-12 protein induction over naïve controls for both the proform and the processed form. In addition, peak induction of the processed form occurred earlier in the hippocampus compared to the cortex (6 h vs. 1 day).
Standard curve generation for semi-quantitative PCR using serially-diluted cDNA The highest levels of caspase-12 transcript expression were observed in ipsilateral cortex and hippocampus from 6 h to 1 day after injury (Fig. 3) . Therefore, total RNA was collected 6 h and 1 day after injury from the ipsilateral cortex and hippocampus, respectively. Total RNA was then reverse transcribed and serially diluted to generate a standard curve of relative amounts of RNA. Samples underwent analysis using the LightCycler PCR with primer sets for caspase-12 or GAPDH mRNA. For each dilution sample (100%, 33.3%, 11.1% and 3.7%), the PCR analysis yielded a crossing point cycle number for each primer pair (caspase-12 or GAPDH-specific). Figure 3 shows the linear regression analysis of each primer set's crossing point cycle number for each brain region versus the logarithm of the dilution factor. For each primer set, the range of crossing point cycle numbers required to cover the serially-diluted standard curve varied: 14-21 cycles for GAPDH, 25-29 cycles for caspase-12 (cortex) and 27-31 cycles for caspase-12 (hippocampus). These differences primarily reflect the abundance of the transcripts. GAPDH mRNA was the most abundant transcript requiring the fewest cycles, whereas caspase-12 hippocampal mRNA was the least abundant transcript and therefore required the most cycles.
Semi-quantitative PCR analysis of experimental samples
Using the standard curves generated as described above, the crossing point cycle numbers were converted to relative amounts of mRNA. These relative amounts were then expressed as percentage of naïve control adjusted for the Fig. 3 Standard curve generation for caspase-12 and GAPDH specific quantitative real-time PCR. Total RNA was extracted from rat ipsilateral hippocampal (6 h post-injury) and cortical (1 day post-injury) tissue for caspase-12 expression and from ipsilateral cortical tissue (3 days post-injury) for GAPDH expression. RNA samples were reverse transcribed and cDNAs were serially diluted. Aliquots of the cDNA dilution curve underwent real-time PCR using primer pairs for caspase-12 mRNA or GAPDH mRNA. For each dilution and each primer set, the cycle number at which the PCR amplification entered the log-linear region was identified (crossing point cycle number). Standard curves were generated by plotting the log concentration of total RNA versus the crossing point cycle number. A linear regression analysis was performed; the r 2 ranged from 0.9895 to 1.000. For quantitation, RNA samples from naïve, sham and injured rats underwent real-time PCR, generating a crossing point cycle number for each primer set. Using the standard curves, the cycle number was converted to an amount of RNA. These amounts are expressed as a percentage of sham control RNA (¼ 100%).
sham effect. Figure 4 shows the time course of caspase-12 mRNA expression in ipsilateral cortex and hippocampus after cortical injury for three magnitudes of injury. The data noticeably convey the similarities in the up-regulation of mRNA levels following injury and illustrate the effect of injury severity on caspase-12 mRNA expression. In the cortex, maximal and statistically significant caspase-12 mRNA expression was observed for all three injury magnitudes 5 days after injury: 1.0 mm, 657% ± 119% (n ¼ 3, p < 0.01); 1.2 mm, 651% ± 65% (n ¼ 3, p < 0.05); and 1.6 mm, 1259% ± 465% (n ¼ 3, p < 0.01). Three days after injury, the 1.2 mm and 1.6 mm injury magnitudes produced significant increases in mRNA expression (p < 0.05 and p < 0.01, respectively), while mild impact (1.0 mm) failed to produce significant increases. However, in the hippocampus, maximal and significant caspase-12 mRNA levels were observed at 6 h for all three injury magnitudes: 1.0 mm, 435% ± 98% (n ¼ 3, p < 0.01); 1.2 mm, 451% ± 10% (n ¼ 3, p < 0.05); and 1.6 mm, 460% ± 36% (n ¼ 3, p < 0.01). Significantly elevated expression was detected at the 1 day (1.0 and 1.6 mm injury, p < 0.05 and p < 0.01, respectively) and 3 day (1.6 mm injury, p < 0.05) time-points.
Immunohistochemical analysis of caspase-12 expression after traumatic injury Ipsilateral and contralateral cortical and hippocampal tissues were examined for caspase-12 induction following TBI. High magnification photomicrographs of the Alexa Fluor stains of uninjured animals revealed healthy cell bodies and little detectable caspase-12 expression (Fig. 5a, panel 1 and Fig. 6a, panel 1) . In contrast, 1 day following injury caspase-12 expression was readily observed in both the ipsilateral cortex and hippocampus, with significant levels in the former immediately below the impact site (Fig. 5 , panels 2 and 6; Fig. 6 , panels 2 and 6).
Immunohistochemical analysis of caspase-12 expression in cortex after traumatic injury
The ipsilateral cortex at the site of the contusion revealed a considerable increase in caspase-12 expression with decreasing levels distal to the site of impact. The morphology of the injury site where the highest levels of caspase-12 induction were located had a decidedly disorganized, almost chaotic appearance when compared to the contralateral and naïve tissue. Caspase-12-immunopositive neurons (Fig. 5a , panel 5) included those cells with apoptotic bodies. It was also clear that caspase-12 was induced in astrocytes at the site of the contusion (Fig. 5b, panel 9 ) but could not be specifically identified in astrocytes distal to this location.
Immunohistochemical analysis of caspase-12 expression in hippocampus after traumatic injury
The ipsilateral hippocampus revealed induction of caspase-12 with caspase-12-immunopositive cells co-localizing with neuronal cell-specific marker NeuN (Fig. 6a, panel 5) but not with the astrocytic marker GFAP (Fig. 6b, panel 9) .
Discussion
This is the first study to show increased expression of caspase-12 mRNA in injured cortex and hippocampus after mild to severe traumatic brain injury in rats, and increased caspase-12 protein expression and processing after severe injury. The study also shows evidence that the increased caspase-12 expression after TBI is found, predominantly, in neurons in the ipsilateral cortex and hippocampus, but also in cortical astrocytes located at the site of the contusion. In the ipsilateral cortex, immunoblot analysis revealed that levels of both the zymogen and the processed form of caspase-12 protein rapidly increased within 6 h of injury, peaking by about 1 day after injury when compared to naïve control. This was followed by a slow decline over the next 2 weeks, with protein levels returning to naïve levels by day 14. In the ipsilateral ) hippocampus. mRNA levels after adjustment for sham effect are expressed as a percentage of naïve control. One-way ANOVA with Dunnet's multiple comparison test was performed to evaluate statistical significance. Comparison of caspase-12 mRNA expression in the ipsilateral cortex (a) from injured animals with naïve control adjusted for sham effect, increased levels of expression were statistically significant at 3 days (1.2 and 1.6 mm injury) and 5 days (1.0, 1.2, and 1.6 mm injury) (*p < 0.05, **p < 0.01).
Comparison of caspase-12 mRNA expression in the ipsilateral hippocampus (b) from injured animals with naïve control adjusted for sham effect, increased levels of expression were statistically significant at 6 h (1.0, 1.2 and 1.6 mm injury), 1 day (1.0 and 1.6 mm injury) and 3 days (1.6 mm injury) after injury (*p < 0.05, **p < 0.01).
hippocampus, caspase-12 protein expression increased rapidly within the first 6 h where expression peaked for the processed form. Levels of the proform peaked later, at 1 day post-injury, when compared with naïve control. The increase in protein expression was more robust in the hippocampus than in the cortex, comparatively speaking.
Immunohistochemical analysis demonstrated that caspase-12 immunoreactivity was considerably increased 24 h following injury when compared with naïve animals, and was found primarily in neurons at the site of the contusion and, to a lesser extent, in areas distal to the site of impact, including the hippocampus (Figs 5 and 6 ). In addition, astrocytes expressing caspase-12 could also be found at the contusion site (Fig. 5b) . However, no astrocytes located distal to this area showed evidence of caspase-12 immunoreactivity. Examination of the NeuN stained tissue at the contusion location, in cells displaying caspase-12 immunoreactivity, showed evidence of pronounced morphological changes when compared with the contralateral side or in naïve animal brain tissue (results not shown). These observations further confirm the previous findings by our laboratory that morphopathological changes occur within 24 h following TBI (Newcomb et al. 1997 (Newcomb et al. , 1999 .
Previous studies of TBI have concentrated on the well characterized extrinsic and intrinsic pathways that were found to be involved in neuronal cell death after TBI (Keane Fig. 5 Immunohistochemical analysis of the ipsilateral cortex in naïve rats and 1 day post-injury rats following controlled cortical impact injury (1.6 mm). (a) Injured brain tissue revealed that caspase-12 is induced in neurons and can be found co-localized in cells showing apoptotic bodies. Naïve brain tissue shows no caspase-12-immunoreactivity (i). In contrast, 1 day, 1.6 mm injured brain tissue revealed immunopositive caspase-12 expression (ii). NeuN stained neuronal cells (iii) show evidence of morphopathology. Apoptotic bodies are clearly present as illustrated by DAPI staining (arrows, iv, see insert for example) and co-localize with caspase-12 and the neuronal cell marker NeuN (arrows, v). Caspase-12 is also seen to co-localize in neurons with NeuN, which do not show apoptotic bodies (curved arrows, v). (b) There is evidence of caspase-12 expression co-localizing in astrocytes at the site of the contusion (arrowheads, ix). Caspase-12 was found primarily in cells that were not labeled with the astrocytic marker GFAP (arrows, ix) including cells showing apoptotic bodies (arrow, viii, see insert), but not in most of the astrocytes examined (curved arrow, ix). Photomicrographs are at 400·; scale bar 20 lm; caspase-12, panels i, ii and vi; NeuN, panel iii; GFAP, panel vii; DAPI, panels iv and viii; co-localized images, panels v and ix. et al. 2001) . The extrinsic apoptotic pathway is triggered by binding of specialized ligands to death domain-containing members of the tumor necrosis factor receptor (TNFR) superfamily, such as Fas and tumor necrosis factor receptor-1 (TNFR-1), allowing for the formation of a death-inducing signaling complex (DISC). Increased expression and interaction of the Fas receptors with FasL ligands (Beer et al. 2000; Qui et al. 2002) and TNFR-1 with TNF (Taupin et al. 1993; Beer et al. 2000) have been demonstrated in TBI. The Fas DISC containing the adaptor protein Fas-associated death domain protein (FADD), and the TNFR-1 DISC containing the TNF-associated receptor with death domain (TRADD), and their respective procaspases-8 and -10, leads to the autoproteolytic processing of these zymogens, initiating the subsequent activation of procaspase-3. The intrinsic pathway involves alterations in mitochondria homeostasis and plays a key role in TBI-associated cell death (Yang et al. 1985; Xiong et al. 1997; Raghupathi et al. 2000) . These disruptions generally involve the release of cytochrome c and the formation of the apoptosome consisting of Apaf-1, dATP, cytochrome c, and the recruitment and activation of caspase-9. Procaspase-9, generally believed to reside in and be released from the mitochondria, is activated during apoptosis and then activates the executioner procaspase-3.
Recent studies have challenged the exclusivity of these two pathways with the discovery that apoptosis is independently induced by an ER stress pathway Rao et al. 2001 Rao et al. , 2002 Yoneda et al. 2001) . The ER is the site for a number of critical processes, including lipid synthesis, maintenance of intracellular Ca 2+ homeostasis, and the synthesis, initial post-translation modification and proper Ca 2+ -dependent folding of most secretory and transmembrane proteins. This includes their sorting and export for delivery to appropriate cellular destinations Caspase-12/Astrocytes 1999; Kaufman 1999; Paschen and Doutheil 1999) . ER functions are disturbed in many acute and chronic diseases of the brain such as global and focal ischemia, ischemia-reperfusion injury that occurs during stroke and cardiac arrest (DeGracia et al. 2002) , epileptic seizures (Pelletier et al. 1999; Henshall et al. 2000) , Alzheimer's disease and TBI (Weber et al. 2001) . A variety of stimuli including changes in the luminal environment (Nakamura et al. 2000) , glucose deprivation, oxidative stress, and the disruption of homeostasis and release of Ca 2+ from the ER, may induce ER stress and subsequently induce apoptosis (Yu et al. 1999; Mattson et al. 2000; Weber et al. 2001) . Any one of these conditions will result in an increase of unfolded or malfolded proteins and the induction of the ER molecular chaperone BiP/GRP78 (Yu et al. 1999; Bertolotti et al. 2000) . The induction of BiP/GRP78 triggers the unfolded protein response. Once activated, the UPR pathway is responsible for communicating changes required to modulate the behavior of the cell, allowing it to adapt and survive or to commit apoptosis. The three stressor proteins found in the ER membrane that generate the response include PERK (also known as PEK), ATF6 and IRE1a. Caspase-12 appears to act within the UPR pathway as a key component of the reaction of IRE1a to trauma and the increase of unfolded or malfolded proteins.
The functions of activated IRE1a, which oligomerizes and transautophosphorylates when released from BiP/GRP78, is complex. Activated IRE1a recruits, via its cytoplasmic domain, JIK (Jun inhibitor kinase) ) into a protein complex with cytosolic adaptor protein TRAF2 (tumor necrosis factor receptor-associated factor-2). TRAF2 is involved in a pro-survival pathway that is dependent on protein synthesis, mediated by activation of NF-jB (Natoli et al. 1997 ) through the interaction with NF-jB-inducing kinase (NIK) (Bradley and Pober 2001; Tada et al. 2001) . The activation of IRE1a stimulates the release of TRAF2 from its stable complex with procaspase-12 .
Caspase zymogens require a minimum of two cleavages to be converted to a mature enzyme, one separating the prodomain from the large subunit and small subunit and a second to separate the two subunits. Once released from TRAF2, procaspase-12, which is found on the cytoplasmic side of the ER, dimerizes in preparation for the initial cleavage by the proteases calpain and/or caspase-7 (Rao et al. 2001) . Calpain has been shown to be activated early in TBI (Pike et al. 1998) . When activated, both proteases are attracted to the ER membrane by some yet unknown mechanism. The processed form of caspase-12 then autoprocesses into the p20 and p10 subdomains, and the resulting two subunits associate to form an (alpha)2(beta)2-tetramer which is the active enzyme. The activation of caspase-12 appears to lead to cellular apoptosis mediated by caspase-9 (Rao et al. 2001 (Rao et al. , 2002 Morishima et al. 2002) and caspase-3.
In contrast to rodent studies, a recent report suggests that the human caspase-12 sequence has acquired deleterious mutations, rendering it non-functional (Fischer et al. 2002) . The study revealed that all splice variants examined had a frame shift mutation and a premature stop codon which would preclude expression of a full length protein. The evidence also points to a loss-of-function mutation within the SHG box, a critical catalytic site in caspases. On the other hand, the authors mentioned a caspase-12 allele residing in the SNP database (dbSNP Acc rs#648264) that restores the open reading frame, suggesting that a full length human caspase-12 allele may exist, but did not choose to pursue this information further. The study was limited to genetic expression and, as a result, no protein expression analysis was done to confirm their conclusions. This analysis is important because currently there are at least five human cell lines with evidence for the presence of caspase-12 protein.
These cell lines include HeLa cells , HEK293T human embryonic kidney cells (Rao et al. 2001; Yoneda et al. 2001) , A549 human lung epithelial cells (Bitko and Barik 2001) , T-ALL CCRF-CEM (subclone CEM-C7H2 vector control cell line, C7H2-VC) human T-cell acute lymphoblastic leukemia cells (Tinhofer et al. 2002) and Huh7 human liver-derived cells (Xie et al. 2002) . These differences will need to be clarified by additional research before human TBI can be interpreted from rodent TBI.
Two recent studies of focal cerebral ischemia in mouse and rat, produced by middle cerebral artery occlusion and the resultant reperfusion injury, offered new evidence that stress to the ER leads to the increase in protein expression of caspase-12, and that it is an important component in neuronal death following ischemia/reperfusion (Mouw et al. 2003; Shibata et al. 2003) . The elements involved in the tissue damage induced by reperfusion include excess free radical production and perturbation of intracellular calcium homeostasis (Paschen and Doutheil 1999), the factors known to trigger ER stress and UPR. The finding by Shibata et al. (2003) that there is increased expression of BiP/GRP78 with the same temporal profile as the increased protein expression of the activated caspase-12 strongly suggests that the ER has been stressed. In addition, they detected DNA fragmentation by TUNEL, a characteristic indication of the occurrence of apoptosis, in many of the caspase-12-positive cells. By using semi-quantitative RT-PCR, Mouw and colleagues (Mouw et al. 2003) observed a significant increase in caspase-12 mRNA in the ipsilateral side of the striatum following ischemia. Both studies found that the increase in caspase-12 protein expression was localized mainly in the ipsilateral striatal neurons. These findings complement our study, suggesting that there is a mechanistic link between the ischemic-like conditions that occur following TBI, the increase in caspase-12 expression, and neuronal death in the cortex and hippocampus.
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Caspase-12 protein induction, in our study, was further supported by semi-quantitative PCR transcript analysis. In both the cortex and the hippocampus, mRNA transcripts showed statistically significant elevation within 3 days of injury and remained elevated for at least 5 days. The delayed and sustained induction of caspase-12 mRNA, in particular in the cortex, suggests the impairment of cellular mechanisms. The cortex may be most vulnerable to this disruption due to its proximity to the injury site. There are several possibilities that are not mutually exclusive. First, it suggests that caspase-12 is involved in protracted apoptosis as well as acute cell death. This is in keeping with the proposal by Rao et al. (2001) that prolonged ER stress may induce further caspase-12 activation via caspase-7, contributing to a delayed but continuing apoptosis through its interaction with caspase-9 (Rao et al. 2001 (Rao et al. , 2002 Morishima et al. 2002) . Second, the normal cellular protein metabolism is most likely impaired. One of the responses of UPR, in response to ER stress, is for there to be a general global inhibition of protein synthesis following the activation of PERK Harding et al. 1999; DeGracia et al. 2002) with exceptions for proteins that will either return the cell to normal activity or commit the cell to apoptosis (Mori et al. 1992; Kohno et al. 1993; Natoli et al. 1997; Yoshida et al. 1998) . There is no evidence to suggest that UPR interferes with mRNA transcription. In addition, there may also be either a decrease in the normal degradation of proteins, including transcription factors, due to the lack of the protein ubiquitin because of the inhibition of protein synthesis, or the process may be overloaded by the UPR as the cell attempts to reduce its backlog of unfolded and malfolded proteins engendered by the ER stress initiated by TBI. A third possibility is that while the transcription of the mRNA continues in response to UPR, the proform is not being transcribed, nor is it being processed to its active form, as the cells regain control over their cellular metabolism. Our study shows the proform returning to normal levels within 7 days; caspase-12 mRNA may follow later. This remains to be determined by future investigations.
The early responses provide compelling evidence that caspase-12 mRNA induction and increased protein expression occur in response to TBI and that caspase-12 may be a major contributor to the more acute pathophysiological events of TBI. In previous studies, caspase-12 has been characterized as an initiator, or upstream, caspase (Rao et al. 2001 (Rao et al. , 2002 . The actual mechanisms and consequences of caspase-12 induction and activation in TBI remain to be examined.
In summary, this study provides the first characterization of caspase-12 mRNA and protein expression and processing in a model of TBI. These findings provide insight into a novel mechanism of cell death following injury. These data also provide clues into the potential ways TBI might contribute to the pathogenesis of a number of neuropathologies through the caspase-12 apoptotic pathway.
